Physician profile
Vikas Garg
NPI 1174775951
$4,123.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $299 · 2021: $478 · 2022: $2,033 · 2023: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $767.54 | 2019-2023 | |
| Janssen Biotech, INC. | $621.08 | 2019-2023 | Stelara |
| Celgene Corporation | $615.00 | 2022-2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $306.52 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.75 | 2020-2022 | |
| Gilead Sciences, INC. | $272.58 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $259.45 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $250.00 | 2019-2022 | |
| Pfizer INC. | $202.79 | 2019-2023 | |
| Intercept Pharmaceuticals, INC. | $143.20 | 2019-2022 | |
| Braintree Laboratories, INC. | $98.58 | 2019-2023 | Sutab |
| E.R. Squibb & Sons, L.L.C. | $80.25 | 2022 | |
| Merck Sharp & Dohme LLC | $66.37 | 2019-2022 | |
| Genzyme Corporation | $54.95 | 2022-2023 | |
| Daiichi Sankyo INC. | $34.88 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32.22 | 2019-2022 | |
| Exact Sciences Corporation | $22.68 | 2023 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $19.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.